Instrument Inactif

Communiqués REMSleep Holdings Inc Other OTC

Actions

US48583T1007

Equipement, fournitures et distribution médicale

Cours en clôture Other OTC
- ^USD	-

14/08	REMSleep Holdings, Inc. publie ses résultats pour le premier semestre clos le 30 juin 2026	CI
10/06	REMSleep Holdings, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Communiqués

04/03	REMSleep Holdings Announces Passing of Founder Thomas Wood and Appointment of Jeffrey Marshall as Chief Executive Officer	EQ
24/02	REMSleep Holdings Announces Full Commercial Launch of DeltaWave(TM)	EQ
30/01	REMSleep Receives Medicare PDAC Coding Approval for Complete DeltaWave Product Portfolio	EQ
15/01	REMSleep Receives Expanded FDA 510(k) Clearance for DeltaWave Nasal Pillow System	EQ
12/01	REMSleep Outlines Q1 2026 Commercial Strategy: Expanded FDA Application, B2B Launch Prep, and Institutional Market Entry	EQ
08/04/25	REMSleep is in Process of Signing Agreement With Major Distributor	AQ
24/02/25	REMSleep Prepares to Launch New FDA Cleared CPAP Pillows Mask to Market	AQ
15/11/24	REMSleep Holdings, Inc. Shareholder Update	AQ
03/09/24	REMSleep Patent Application Has Been Allowed by the United States Patent and Trademark Office	GL
06/08/24	REMSleep Holdings Inc. Issues Shareholder Letter	AQ
24/07/24	REMSleep Holdings, Inc. Announces Distributor Request for DELTAWAVE Nasal Pillows System Samples	AQ
17/07/24	REMSleep Holdings Inc. Announces Strategic Marketing Plan for DELTAWAVE Nasal Pillows System	AQ
09/07/24	REMSleep Holdings Inc. Receives 510(K) Clearance on Product	AQ
03/07/24	REMSleep 510(K) Submission	AQ
30/05/24	REMSleep Holdings Shareholder Update	AQ
06/03/24	REMSleep Holdings Patent Status	AQ
04/03/24	REMSleep Holdings Shareholder Update	AQ
22/01/24	Remsleep Holdings Inc.'s DeltaWave Mask has received questions from FDA regarding 510k submission (K233415)	AQ
17/04/23	REMSLEEP HOLDINGS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
06/01/23	RemSleep Holdings Inc. Issues Letter to Shareholders	AQ
14/11/22	REMSLEEP HOLDINGS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN OF OPERATIONS. (form 10-Q)	AQ
08/11/22	RemSleep Holdings Provides a Corporate Update on Testing	AQ
22/08/22	REMSLEEP HOLDINGS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN OF OPERATIONS. (form 10-Q)	AQ
27/07/22	RemSleep Holdings Inc. Commences Trading on OTCQB	AQ
22/07/22	RemSleep Holdings Inc. Engages New Senior Director for Regulatory Compliance and New Regulatory Testing Company	AQ